CN1385203A - Compound Chinese medicine preparation of damnacanthus - Google Patents
Compound Chinese medicine preparation of damnacanthus Download PDFInfo
- Publication number
- CN1385203A CN1385203A CN02115921A CN02115921A CN1385203A CN 1385203 A CN1385203 A CN 1385203A CN 02115921 A CN02115921 A CN 02115921A CN 02115921 A CN02115921 A CN 02115921A CN 1385203 A CN1385203 A CN 1385203A
- Authority
- CN
- China
- Prior art keywords
- herba
- radix
- damnacanthi
- chinese medicine
- medicine preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The compound damnacanthus Chinese medicine preparation is made of 11 Chinese medicinal materials of damnacanthus, bupleurum root, scuttelaria root, busky knotweed root, hydyotis and others. Said medicine preparation has the effective active components (several anthraquinone compounds and their derivatives) of damnacanthus, so that it possesses the functions of clearing away heat, removing toxic material, protecting liver, softening liver and dissipating binds, etc.
Description
[technical field]
The invention belongs to medical preparation, relate to a kind of compound recipe Herba Damnacanthi Chinese medicine preparation.
[background technology]
China is the zone occurred frequently of hepatitis B disease, and the present special effect medicine that treating hepatitis B is not arranged as yet, the viewpoint that Chinese medicine can be captured hepatopathy more and more becomes people's common recognition, for catching people's attention, in the prior art only patent application the hundreds of item is just arranged, as application number: 01122252, " live-nourishing ' yanggan ' pill " by name, it consists of Radix Glycyrrhizae, Fructus Schisandrae Chinensis, Endothelium Corneum Gigeriae Galli, Radix Ginseng, Radix Angelicae Sinensis, Herba Artemisiae Scopariae, Carapax Trionycis, Radix Salviae Miltiorrhizae, Fructus Jujubae, Folium Isatidis, the Radix Astragali, Rhizoma Imperatae.And for example application number is: 99113887 " a kind of medicines for the treatment of chronic hepatopathy and preparation method thereof " by name relate to medicine and are: Semen Persicae, Radix Salviae Miltiorrhizae, Herb Gynostemmae Pentaphylli, fermented Cordyceps powder, loose medicated powder, Fructus Schisandrae Chinensis and appropriate amount of starch.Or the like.
[summary of the invention]
The present invention is to serve as the main a kind of compound recipe Herba Damnacanthi Chinese medicine preparation that is equipped with other medicines treatment hepatitis B in order to provide with the Herba Damnacanthi curative effect.
The present invention is achieved in that mainly and is made up of Herba Damnacanthi, Radix Bupleuri, Radix Scutellariae, Rhizoma Polygoni Cuspidati, Herba Hedyotidis Diffusae, Herba Scutellariae Barbatae, Herba Abri, Herba Sedi, Formica fusca, Rhizoma Smilacis Glabrae, Radix Glycyrrhizae that percentage by weight is between its each composition:
Herba Damnacanthi 9～13%
Radix Bupleuri 1～5%
Radix Scutellariae 3～8%
Rhizoma Polygoni Cuspidati 6～10%
Herba Hedyotidis Diffusae 14～18%
Herba Scutellariae Barbatae 14～18%
Herba Abri 9～13%
Herba Sedi 6～10%
Formica fusca 3～8%
Rhizoma Smilacis Glabrae 9～13%
Radix Glycyrrhizae 1～5%
To require adopting " the two thorns of spire " Herba Damnacanthi, i.e. short Herba Damnacanthi in the selection of Herba Damnacanthi, behind selected in proportion each composition, preparation technology uses " specification requirement of new Chinese medicine Study on Preparation " in principle, the effective constituent that mainly contains that uses modern preparation new technique to extract medicine is used as medicine, add some accessory substances, as water, sugar, starch etc., can be made into capsule, granule, electuary, tablet, oral liquid.
The present invention uses specific Chinese medicine preparation to form treatment hepatitis B new drug, and outstanding Chinese medicine Herba Damnacanthi is main medicine, and its effective active chemical compound (multiple anthraquinone analog compound and derivant thereof) is used as medicine, and clinical have a heat-clearing and toxic substances removing, and enzyme falls in hepatoprotective, the effect of soft liver eliminating stagnation.It is fast stable to recover the sign curative effect, treats to reach rehabilitation effect in 30 days substantially, and after treatment 2～3 months reaches the clinical cure effect.No rebound phenomenon, no toxicity, safe and reliable.
The present invention is further provided by following.
The function of each composition of the present invention and curative effect:
Herba Damnacanthi: heat-clearing and toxic substances removing, hard masses softening and resolving, expelling wind and removing dampness, stasis-dispelling and pain-killing.The clinical diseases such as hepatitis, hepatosplenomegaly, traumatic injury, rheumatic arthritis, gout, dyspepsia, menoxenia, tracheitis, cancerous protuberance that are used for the treatment of.Pharmacological research shows, hepatoprotective is arranged, falls enzyme, the effect of fibrosis, the multiple cancerous protuberance of inhibition.Be our principal agent.
Radix Bupleuri: depressed liver-energy dispersing and function of gallbladder promoting, the resolving depression eliminating stagnation is conciliate heat radiation.Pharmacological research shows, the cytopathy that has hepatitis virus resisting to cause obviously suppresses the fibroplasia effect, promotes immunity of organism, anti-fatty liver, and effects such as enzyme fall in hepatic cholagogic.
Radix Scutellariae: heat-clearing and toxic substances removing, dampness removing jaundice eliminating.Pharmacological research shows the hepatoprotective function of gallbladder promoting is arranged, fall enzyme, eliminate the hepatitis B virus effect.Simultaneously, with the Radix Bupleuri contract, there is priming to go into the Liver Channel effect.
Rhizoma Polygoni Cuspidati: heat-clearing and toxic substances removing, dampness removing jaundice eliminating, promoting blood circulation to remove blood stasis, pain relieving.Pharmacological research shows that hepatitis B virus is had stronger inhibitory action, and impaired hepatocyte is had reparation, regeneration.
Herba Hedyotidis Diffusae: clearing away heat-damp and promoting diuresis, the dissipating blood stasis detoxifcation, anticancer.Pharmacological research shows, can regulate and control immunity, suppresses and kills hepatitis B virus, transaminase lowering effect.Can stimulate the hypertrophy of reticuloendothelial system, the liver tissues inflammatory reaction is taken a turn for the better and the decline of hepatic necrosis program, prevent the effect of hepatic fibrosis and canceration.
Herba Scutellariae Barbatae: heat-clearing and toxic substances removing, the removing heat from blood block up that looses, hemostasis analgesic therapy, inducing diuresis to eliminate dampness.Pharmacological research shows that tangible removing hepatocyte edema, jaundice eliminating effect are arranged.
Herba Abri: heat-clearing and toxic substances removing, dampness removing and in, the soothing liver-QI dissipating blood stasis, the conditioning liver and gall.Pharmacological research shows that the hepatoprotective choleretic effect is obvious.
Herba Sedi: clearing away heat-damp and promoting diuresis, detoxifcation.Pharmacological research shows have tangible hepatoprotective to fall enzyme, suppresses the hepatitis B virus effect.
Formica fusca: contain several amino acids, a large amount of vitamin and various trace elements are immunomodulators.Pharmacological research shows that transaminase lowering is arranged, and removes virus function.
Rhizoma Smilacis Glabrae: eliminating damp-heat, separate noxious dampness, eliminating evil collateral dredging.Pharmacological research shows that the detoxication of hepatitis B toxin expelling is had facilitation.
Radix Glycyrrhizae: heat-clearing and toxic substances removing, coordinating the actions of various ingredients in a prescription.Pharmacological research shows to have the anti-liver injury effect, shows as ballooning degeneration of liver cells and alleviates, and recover rapidly the necrotic area, and the transaminase descends, and also has antiinflammatory, detoxifcation, inhibition fibrosis effect simultaneously.
[specific embodiment]
Percentage by weight is between embodiment 1 each composition of employing:
Herba Damnacanthi 11%
Radix Bupleuri 4.4%
Radix Scutellariae 3.6%
Rhizoma Polygoni Cuspidati 8.4%
Herba Hedyotidis Diffusae 14.8%
Herba Scutellariae Barbatae 14.8%
Herba Abri 13%
Herba Sedi 9.4%
Formica fusca 7.6%
Rhizoma Smilacis Glabrae 11.5%
Radix Glycyrrhizae 2.5%
Percentage by weight is between embodiment 2 described each composition:
Herba Damnacanthi 11%
Radix Bupleuri 3.4%
Radix Scutellariae 5.6%
Rhizoma Polygoni Cuspidati 8.4%
Herba Hedyotidis Diffusae 16.8%
Herba Scutellariae Barbatae 16.8%
Herba Abri 11%
Herba Sedi 8.4%
Formica fusca 5.6%
Rhizoma Smilacis Glabrae 11%
Radix Glycyrrhizae 2%
Percentage by weight is between embodiment 3 described each composition:
Herba Damnacanthi 13%
Radix Bupleuri 2.4%
Radix Scutellariae 4.6%
Rhizoma Polygoni Cuspidati 9.4%
Herba Hedyotidis Diffusae 14.8%
Herba Scutellariae Barbatae 17.8%
Herba Abri 10%
Herba Sedi 7.4%
Formica fusca 4.6%
Rhizoma Smilacis Glabrae 13%
Radix Glycyrrhizae 3%
Get above composition in proportion and be crushed to about 100 orders, add an amount of water, sugar is made granule, electuary, oral liquid.Or add an amount of starch again and can be made into tablet.
Preparation technology uses " specification requirement of new Chinese medicine Study on Preparation " in principle, use modern preparation new technique, the effective constituent that mainly contains that keeps described medicine is used as medicine, and adds some accessory substances, and the interpolation of accessory substance can not influence the percentage ratio between described each composition.
Claims (4)
1, a kind of compound recipe Herba Damnacanthi Chinese medicine preparation is characterized in that: mainly be made up of Herba Damnacanthi, Radix Bupleuri, Radix Scutellariae, Rhizoma Polygoni Cuspidati, Herba Hedyotidis Diffusae, Herba Scutellariae Barbatae, Herba Abri, Herba Sedi, Formica fusca, Rhizoma Smilacis Glabrae, Radix Glycyrrhizae, percentage by weight is between its each composition:
Herba Damnacanthi 9～13%
Radix Bupleuri 1～5%
Radix Scutellariae 3～8%
Rhizoma Polygoni Cuspidati 6～10%
Herba Hedyotidis Diffusae 14～18%
Herba Scutellariae Barbatae 14～18%
Herba Abri 9～13%
Herba Sedi 6～10%
Formica fusca 3～8%
Rhizoma Smilacis Glabrae 9～13%
Radix Glycyrrhizae 1～5%
2, a kind of compound recipe Herba Damnacanthi Chinese medicine preparation according to claim 1, it is characterized in that: percentage by weight is between described each composition:
Herba Damnacanthi 11%
Radix Bupleuri 4.4%
Radix Scutellariae 3.6%
Rhizoma Polygoni Cuspidati 8.4%
Herba Hedyotidis Diffusae 14.8%
Herba Scutellariae Barbatae 14.8%
Herba Abri 13%
Herba Sedi 9.4%
Formica fusca 7.6%
Rhizoma Smilacis Glabrae 11.5%
Radix Glycyrrhizae 1.5%
3, a kind of compound recipe Herba Damnacanthi Chinese medicine preparation according to claim 1, it is characterized in that: percentage by weight is between described each composition:
Herba Damnacanthi 11%
Radix Bupleuri 3.4%
Radix Scutellariae 5.6%
Rhizoma Polygoni Cuspidati 8.4%
Herba Hedyotidis Diffusae 16.8%
Herba Scutellariae Barbatae 16.8%
Herba Abri 11%
Herba Sedi 8.4%
Formica fusca 5.6%
Rhizoma Smilacis Glabrae 11%
Radix Glycyrrhizae 2%
4, a kind of compound recipe Herba Damnacanthi Chinese medicine preparation according to claim 1, it is characterized in that: percentage by weight is between described each composition:
Herba Damnacanthi 13%
Radix Bupleuri 2.4%
Radix Scutellariae 4.6%
Rhizoma Polygoni Cuspidati 9.4%
Herba Hedyotidis Diffusae 14.8%
Herba Scutellariae Barbatae 17.8%
Herba Abri 10%
Herba Sedi 7.4%
Formica fusca 4.6%
Rhizoma Smilacis Glabrae 13%
Radix Glycyrrhizae 3%
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021159211A CN1183937C (en) | 2002-05-31 | 2002-05-31 | Compound Chinese medicine preparation of damnacanthus |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021159211A CN1183937C (en) | 2002-05-31 | 2002-05-31 | Compound Chinese medicine preparation of damnacanthus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1385203A true CN1385203A (en) | 2002-12-18 |
| CN1183937C CN1183937C (en) | 2005-01-12 |
Family
ID=4743948
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB021159211A Expired - Fee Related CN1183937C (en) | 2002-05-31 | 2002-05-31 | Compound Chinese medicine preparation of damnacanthus |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1183937C (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101199630B (en) * | 2007-10-22 | 2011-07-20 | 黄仁彬 | Drug for treating hepatitis B |
| CN102552486A (en) * | 2012-03-28 | 2012-07-11 | 王靖敏 | Preparation method of anti-hepatitis B virus oral liquid |
| CN105126027A (en) * | 2015-09-11 | 2015-12-09 | 谢大暄 | Plaster for treating hepatitis B |
| CN111905033A (en) * | 2020-09-03 | 2020-11-10 | 古广雄 | A Chinese medicinal composition for treating three positive and small positive symptoms, liver cirrhosis, and hepatic ascites |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107281327A (en) * | 2017-04-28 | 2017-10-24 | 江西康之康中药科技有限公司 | A kind of Chinese medicine composition for preventing and treating hepatitis B |
-
2002
- 2002-05-31 CN CNB021159211A patent/CN1183937C/en not_active Expired - Fee Related
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101199630B (en) * | 2007-10-22 | 2011-07-20 | 黄仁彬 | Drug for treating hepatitis B |
| CN102552486A (en) * | 2012-03-28 | 2012-07-11 | 王靖敏 | Preparation method of anti-hepatitis B virus oral liquid |
| CN102552486B (en) * | 2012-03-28 | 2013-07-24 | 王靖敏 | Preparation method of anti-hepatitis B virus oral liquid |
| CN105126027A (en) * | 2015-09-11 | 2015-12-09 | 谢大暄 | Plaster for treating hepatitis B |
| CN111905033A (en) * | 2020-09-03 | 2020-11-10 | 古广雄 | A Chinese medicinal composition for treating three positive and small positive symptoms, liver cirrhosis, and hepatic ascites |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1183937C (en) | 2005-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1695694A (en) | Chinese traditional medicine for treating breast disease and preparing technique | |
| CN1095674C (en) | Chinese medicinal composition for cerebrovascular disease, rheumatism and rheumatoid disease | |
| CN1927374A (en) | Traditional Chinese medicine for treating hepatitis B and its preparing process | |
| CN1183937C (en) | Compound Chinese medicine preparation of damnacanthus | |
| CN1457834A (en) | Detoxicating pill | |
| CN1245173C (en) | Medicine composition for treating liver fibrillation and liver cirrhosis and its prepn process | |
| CN1166388C (en) | Medicine for treating nosal inflammation | |
| CN1298362C (en) | Compound Chinese medicine prepn for treating pulvic infection and its prepn process | |
| CN1600333A (en) | Painkiller | |
| CN102049006A (en) | Traditional Chinese medicine formula for treating verruca | |
| CN1102104A (en) | Adhesive plaster capable of detoxicating and resolving a mass | |
| CN1772126A (en) | Antiphlogistic medicine | |
| CN1066047C (en) | Traditional Chinese medicine preparation for treatment of sharp-pointed condyloma | |
| CN1899574A (en) | Chinese medicine composition for preventing and controlling liver cancer and its use | |
| CN1098092C (en) | Rheumatism capsule | |
| CN1679887A (en) | Chinese medicine composition for treating hepatitis | |
| CN1319578C (en) | Prescription of Chinese medicine compound preparation, its preparation method and use | |
| CN1261130C (en) | Medicine for dispelling tinea | |
| CN1172701C (en) | Medicine for curing herpes zoster | |
| CN103893586A (en) | Traditional Chinese medicine for treating acute tonsillitis | |
| CN1099876C (en) | Medicine for curing psoriasis | |
| CN1212150C (en) | Medicine for treating virus hepatitis and its preparation method | |
| CN1879846A (en) | A Chinese medicinal preparation for treating rheumatism, hyperosteogeny and osteoporosis and method for preparing same | |
| CN1150016C (en) | Medicine for treating fever caused by lupus erythematosus and other immunological disease | |
| CN1973880A (en) | Externally applied medicine for treating gouty arthritis and its prepn |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |